Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Prepublished online as a Blood First Edition Paper on August 8, 2002; DOI 10.1182/blood-2002-05-1552.

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2002-05-1552v1
100/13/4660    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by BitMansour, A.
Right arrow Articles by Brown, J. M. Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by BitMansour, A.
Right arrow Articles by Brown, J. M. Y.
Related Collections
Right arrow Transplantation
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

Blood, 15 December 2002, Vol. 100, No. 13, pp. 4660-4667

TRANSPLANTATION

Myeloid progenitors protect against invasive aspergillosis and Pseudomonas aeruginosa infection following hematopoietic stem cell transplantation

Andrew BitMansour, Stacy M. Burns, David Traver, Koichi Akashi, Christopher H. Contag, Irving L. Weissman, and Janice M. Y. Brown

From the Divisions of Bone Marrow Transplantation and Infectious Diseases, Department of Medicine; Department of Pathology; and Departments of Pediatrics and Microbiology and Immunology; Stanford University School of Medicine, CA.

Myelotoxic treatments for oncologic diseases are often complicated by neutropenia, which renders patients susceptible to potentially lethal infections. In these studies of murine hematopoietic stem cell transplantation (HSCT), cotransplantation of lineage-restricted progenitors known as common myeloid progenitors (CMP) and granulocyte-monocyte progenitors (GMP) protects against death following otherwise lethal challenge with either of 2 pathogens associated with neutropenia: Aspergillus fumigatus and Pseudomonas aeruginosa. Cotransplantation of CMP/GMP resulted in a significant and rapid increase in the absolute number of myeloid cells in the spleen, most of which were derived from the donor CMP/GMP. Despite persistent peripheral neutropenia, improved survival correlated with the measurable appearance of progenitor-derived myeloid cells in the spleen. A marked reduction or elimination of tissue pathogen load was confirmed by culture and correlated with survival. Localization of infection by P aeruginosa and extent of disease was also assessed by in vivo bioluminescent imaging using a strain of P aeruginosa engineered to constitutively express a bacterial luciferase. Imaging confirmed that transplantation with a graft containing hematopoietic stem cells and CMP/GMP reduced the bacterial load as early as 18 hours after infection. These results demonstrate that enhanced reconstitution of a tissue myeloid pool offers protection against lethal challenge with serious fungal and bacterial pathogens.

© 2002 by The American Society of Hematology.
 

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
BloodHome page
S. Rodriguez, A. Chora, B. Goumnerov, C. Mumaw, W. S. Goebel, L. Fernandez, H. Baydoun, H. HogenEsch, D. M. Dombkowski, C. A. Karlewicz, et al.
Dysfunctional expansion of hematopoietic stem cells and block of myeloid differentiation in lethal sepsis
Blood, November 5, 2009; 114(19): 4064 - 4076.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
N. V. Serbina, M. Cherny, C. Shi, S. A. Bleau, N. H. Collins, J. W. Young, and E. G. Pamer
Distinct Responses of Human Monocyte Subsets to Aspergillus fumigatus Conidia
J. Immunol., August 15, 2009; 183(4): 2678 - 2687.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
I. L. Weissman and J. A. Shizuru
The origins of the identification and isolation of hematopoietic stem cells, and their capability to induce donor-specific transplantation tolerance and treat autoimmune diseases
Blood, November 1, 2008; 112(9): 3543 - 3553.
[Abstract] [Full Text] [PDF]


Home page
ASH ANNUAL MEETING ABSTRACTSHome page
J. Domen, M. Wahedi, E. Danenberg, S. Smith-Berdan, J. Christensen, T. Fong, and J. Brown
Neutropenic Mice Can Be Protected from Fungus Infection by Ex Vivo Expanded Allogeneic Myeloid Progenitors.
Blood (ASH Annual Meeting Abstracts), November 16, 2005; 106(11): 3038 - 3038.
[Abstract]


Home page
JAMAHome page
I. Weissman
Stem Cell Research: Paths to Cancer Therapies and Regenerative Medicine
JAMA, September 21, 2005; 294(11): 1359 - 1366.
[Abstract] [Full Text] [PDF]


Home page
J Antimicrob ChemotherHome page
S. Bellocchio, R. Gaziano, S. Bozza, G. Rossi, C. Montagnoli, K. Perruccio, M. Calvitti, L. Pitzurra, and L. Romani
Liposomal amphotericin B activates antifungal resistance with reduced toxicity by diverting Toll-like receptor signalling from TLR-2 to TLR-4
J. Antimicrob. Chemother., February 1, 2005; 55(2): 214 - 222.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
R. Gaziano, S. Bozza, S. Bellocchio, K. Perruccio, C. Montagnoli, L. Pitzurra, G. Salvatori, R. De Santis, P. Carminati, A. Mantovani, et al.
Anti-Aspergillus fumigatus Efficacy of Pentraxin 3 Alone and in Combination with Antifungals
Antimicrob. Agents Chemother., November 1, 2004; 48(11): 4414 - 4421.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
L. Romani, F. Bistoni, R. Gaziano, S. Bozza, C. Montagnoli, K. Perruccio, L. Pitzurra, S. Bellocchio, A. Velardi, G. Rasi, et al.
Thymosin {alpha} 1 activates dendritic cells for antifungal Th1 resistance through Toll-like receptor signaling
Blood, June 1, 2004; 103(11): 4232 - 4239.
[Abstract] [Full Text] [PDF]


Home page
ASH Education BookHome page
N. J. Chao, S. G. Emerson, and K. I. Weinberg
Stem Cell Transplantation (Cord Blood Transplants)
Hematology, January 1, 2004; 2004(1): 354 - 371.
[Abstract] [Full Text] [PDF]


Home page
ASH Education BookHome page
J. R. Wingard, W. G. Nichols, and G. B. McDonald
Supportive Care
Hematology, January 1, 2004; 2004(1): 372 - 389.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S. Bozza, K. Perruccio, C. Montagnoli, R. Gaziano, S. Bellocchio, E. Burchielli, G. Nkwanyuo, L. Pitzurra, A. Velardi, and L. Romani
A dendritic cell vaccine against invasive aspergillosis in allogeneic hematopoietic transplantation
Blood, November 15, 2003; 102(10): 3807 - 3814.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
C. Arber, A. BitMansour, T. E. Sparer, J. P. Higgins, E. S. Mocarski, I. L. Weissman, J. A. Shizuru, and J. M. Y. Brown
Common lymphoid progenitors rapidly engraft and protect against lethal murine cytomegalovirus infection after hematopoietic stem cell transplantation
Blood, July 15, 2003; 102(2): 421 - 428.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2002 by American Society of Hematology         Online ISSN: 1528-0020